PHARMACEUTICAL COMPOSITION OF KOR RECEPTOR AGONIST

Disclosed in the present invention is a pharmaceutical composition of a KOR receptor agonist, which comprises 4-amino-N-[N2-[N-[N-[N-((R)-2-phenyl propyl)glycyl]-D-phenylalanyl]-D-leucyl]-D-lysyl]piperidine-4-c arboxylic acid or available salts thereof, and an acetate buffer solution. En la presente...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZHOU Yin, ZOU Aifeng, TAO Weikang, FAN Yi, TONG Xinyong
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed in the present invention is a pharmaceutical composition of a KOR receptor agonist, which comprises 4-amino-N-[N2-[N-[N-[N-((R)-2-phenyl propyl)glycyl]-D-phenylalanyl]-D-leucyl]-D-lysyl]piperidine-4-c arboxylic acid or available salts thereof, and an acetate buffer solution. En la presente invención se describe una composición farmacéutica de un agonista del receptor KOR, que comprende 4-amino-N- [N2- [N- [N- [N - ((R) -2-fenilpropil) glicil] -D- ácido fenilalanil] -D-leucil] -D-lisil] piperidin-4-carboxílico o sales disponibles del mismo, y una solución buffer de acetato.